The Advanced Wound Care Market in Europe has been estimated at USD 2.8 billion in 2020 and is projected to reach USD 3.51 billion by 2025, at a CAGR of 4.63%.
People afflicted with chronic wounds, which take a significant amount of time to heal and are expensive to treat, have received much-needed relief in the form of Advanced Wound Care products. Technology has leapfrogged in this area. Advanced wound care products are preferred to traditional wound care products due to their effectiveness in enabling faster healing. Advanced Wound care market caters available and user-friendly products to the afflicted patients. Treatment in advanced wound care includes intervention therapies and products such as collagen products, foam dressings, hydrocolloids, alginate dressings, gauze composites, and hydrogels. As technology advances and becomes a much more viable option, the quality of life of patients afflicted with chronic wounds in Europe rises.
The major factors driving the advanced wound care market in the European region are the growing occurrence rate of injured wounds, the increasing rate of diabetes occurrence, and a rising number of surgeries like a cesarean and many more. The growth of the advanced wound care market was achieved by new drugs and product launches, mergers, and collaboration of different stakeholders and key players, advancements in technologies towards the superior wound care products in the past couple of years. Having excellent knowledge about wound management, increasing claims for wound care is surging the market growth in the United Kingdom . Every year around 2.2 million adults in the UK are found to have a wound as the number of wound cases in the UK increases with the highest CAGR.
An increasingly aging population mainly drives the European market, growing incidences of chronic wounds and diabetes, technological advances, increasing hospital costs, and policies undertaken by the government. The Incidences of various types of Ulcers, such as Pressure Ulcers, leg Ulcers, and foot Ulcers, etc., vary between 0.07% to 0.09%. Also, 0.24% of the population in Europe is experiencing Chronic Wounds. In 2018, approximately 19 % of the people in Europe were aged 65 and more. The share of people aged 80 years or more should more than double by 2100 to reach 14.6 % of the population. This geriatric population acted as a driver to this market.
The volume of surgical procedures has been increased consistently. Various surgeries, such as hip implant surgeries, major peritoneal surgeries, thoracic surgeries, and ENT surgeries, along with the surgeries for the central nervous system, were carried out. There is a growing demand for faster recovery from wounds. Specialized medical staplers known as surgical staplers are used as wound closures in place of sutures. The need for minimally invasive surgeries has risen, leading to the expansion of the surgical staplers’ segment.
Reimbursement issues and cost issues serve as factors that hinder the market in Europe. There are inadequate reimbursement policies undertaken by the government, and this attribute is hampering the market's growth rate. The cost associated with the procedure is expensive.
This report on European Advanced Wound Care Market has been segmented and sub-segmented into the following categories:
Europe Advanced Wound Care Market - By Type:
Based on type, the dressing segment accounts for the most significant portion of the European market. However, active wound care is the fastest-growing segment in this category.
Europe Advanced Wound Care Market - By Application:
Based on the application, the surgical wounds segment leads to the European market. However, skin ulcer is the fastest-growing segment in this category.
Europe Advanced Wound Care Market - By End-User:
Based on end-user, the inpatient facilities segment grabs the most substantial chunk of the European market. However, outpatient service is the fastest-growing segment in this category.
Europe Advanced Wound Care Market - By Country:
Regionally, Europe has the second-largest market for Advanced Wound Care products, after North America. The Europe Advanced Wound Care Market in this region has more significance with trends showing that people desire more efficient solutions for their illnesses. This technology is especially inclined towards the elderly population in Europe, for whom easily accessible healthcare is paramount.
Within Europe, the Germany Advanced Wound Care Market is projected to lead the European advanced wound care market and is expected to continue its dominance throughout the period and owes to advanced technologies, growing government funds, and investments towards wound care research fueling the market. Moreover, increasing demand for active wound care products and the treatment associated with them, particularly those in emerging nations, are likely to offer better opportunities. However, the cost associated with the procedure is so expensive, which can’t be affordable. Also, inadequate reimbursement policies towards the market may hamper the growth of this country in this region.
The UK advanced wound care market is expected to have a quick CAGR growth during the period, and the increase is due to the growing occurrence of diabetes, which leads to the market growth of this region. The other factors also include lifestyle disorders like foot ulcers, pressure ulcers, and venous ulcers, which propel the market. In the UK, every year, nearly 3.8million people have diabetes. Moreover, the product approvals and their advancements in product technologies drive the UK market. The UK based company Advanced Medical Solution Group plc has received FDA acceptance for high-performance dressing and silicone PHMB dressings from the US, which will assist in ease of launching the products in the market to specific regions that may also influence the market growth.
Notable companies operating in the Europe Advanced Wound Care Market are Acelity L.P., Inc., Smith and Nephew Plc., Mölnlycke Health Care, ConvaTec, Inc., Coloplast Corp., 3M Healthcare, Medtronic, Integra Lifesciences Corporation and Organogenesis Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.2 Therapy Devices
5.1.3 Active wound care
5.2 By Application
5.2.1 Skin ulcers
5.2.2 Surgical wounds
5.2.3 Burn wounds
5.3 By End User
5.3.1 In-patient services
6.1 United Kingdom
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.3 3M Health care
8.5 Integra Lifesciences
8.6 Derma Sciences
8.8 Smith & Nephew
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities